Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
051905.KS Stock Summary
In the News
051905.KS Financial details
Company Rating
Buy
Market Cap
11326.19B
Income
482.47B
Revenue
7401.08B
Book val./share
326424.02
Cash/share
-
Dividend
4050
Dividend %
1.36%
Employees
4.38K
Optionable
No
Shortable
Yes
Earnings
-
P/E
10.33
Forward P/E
-
PEG
-2.61
P/S
0.67
P/B
0.91
P/C
-
P/FCF
10.5
Quick Ratio
-
Current Ratio
1.78
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
28.79K
EPS next Y
-
EPS next Q
-
EPS this Y
21.04%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
9.74%
Revenue last 5Y
5.23%
Revenue Q/Q
0.41%
EPS Q/Q
0.95%
-
-
-
-
SMA20
-0.84%
SMA50
-0.88%
SMA100
-14.02%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
9%
ROC
0.13%
Gross Margin
57%
Oper. Margin
11%
Profit Margin
7%
Payout
14%
Shs Outstand
2.1M
Shs Float
11.43M
-
-
-
-
Target Price
-
52W Range
275500.0-574000.0
52W High
-48.17%
52W Low
+7.99%
RSI
43.41
Rel Volume
0.37
Avg Volume
19.03K
Volume
6.99K
Perf Week
-3.25%
Perf Month
-1.65%
Perf Quarter
-20.13%
Perf Half Y
-23.23%
-
-
-
-
Beta
0.980034
-
-
Volatility
10639.26%, 7183.7%
Prev Close
0.17%
Price
297500
Change
-0.67%
051905.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 427.73K | 460.28K | 524.25K | 535.1K | 551.95K | |
Net income per share | 41.38K | 46.57K | 53.08K | 54.41K | 57.61K | |
Operating cash flow per share | 50.17K | 55.74K | 77.74K | 68.54K | 67.16K | |
Free cash flow per share | 30.33K | 30.9K | 54.88K | 33.15K | 44.5K | |
Cash per share | 27.5K | 28.21K | 49.07K | 33.6K | 56.61K | |
Book value per share | 204.44K | 239.57K | 282.86K | 324.42K | 367.54K | |
Tangible book value per share | 115.27K | 139.77K | 167.11K | 190.03K | 227.09K | |
Share holders equity per share | 204.44K | 239.57K | 282.86K | 324.42K | 367.54K | |
Interest debt per share | 42.16K | 33.53K | 48.78K | 32.84K | 36.45K | |
Market cap | 9763.42B | 11024.16B | 11288.03B | 10261.85B | 8033.56B | |
Enterprise value | 9981.29B | 11108.94B | 11342.17B | 10296.63B | 7820.8B | |
P/E ratio | 16.09 | 16.15 | 14.51 | 12.87 | 9.51 | |
Price to sales ratio | 1.56 | 1.63 | 1.47 | 1.31 | 0.99 | |
POCF ratio | 13.27 | 13.49 | 9.9 | 10.21 | 8.16 | |
PFCF ratio | 21.96 | 24.34 | 14.03 | 21.12 | 12.32 | |
P/B Ratio | 3.26 | 3.14 | 2.72 | 2.16 | 1.49 | |
PTB ratio | 3.26 | 3.14 | 2.72 | 2.16 | 1.49 | |
EV to sales | 1.59 | 1.65 | 1.48 | 1.31 | 0.97 | |
Enterprise value over EBITDA | 9.88 | 9.97 | 8.42 | 7.46 | 5.36 | |
EV to operating cash flow | 13.57 | 13.6 | 9.95 | 10.25 | 7.94 | |
EV to free cash flow | 22.45 | 24.52 | 14.1 | 21.19 | 11.99 | |
Earnings yield | 0.06 | 0.06 | 0.07 | 0.08 | 0.11 | |
Free cash flow yield | 0.05 | 0.04 | 0.07 | 0.05 | 0.08 | |
Debt to equity | 0.09 | 0.03 | 0.06 | 0.04 | 0.03 | |
Debt to assets | 0.35 | 0.32 | 0.35 | 0.29 | 0.27 | |
Net debt to EBITDA | 0.22 | 0.08 | 0.04 | 0.03 | -0.15 | |
Current ratio | 1.22 | 1.24 | 1.22 | 1.34 | 1.62 | |
Interest coverage | 66.67 | 102.62 | 84.82 | 97.61 | 102.96 | |
Income quality | 1.21 | 1.2 | 1.46 | 1.26 | 1.17 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Payout ratio | 0.22 | 0.24 | 0.2 | 0.25 | 0.22 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.29 | 0.29 | 0.28 | 0.3 | 0.29 | |
Capex to operating cash flow | -0.4 | -0.45 | -0.29 | -0.52 | -0.34 | |
Capex to revenue | -0.05 | -0.05 | -0.04 | -0.07 | -0.04 | |
Capex to depreciation | -1.99 | -2.31 | -1.33 | -1.98 | -1.21 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 436.3K | 501.04K | 581.21K | 630.21K | 690.21K | |
ROIC | 0.26 | 0.27 | 0.25 | 0.23 | 0.21 | |
Return on tangible assets | 0.18 | 0.18 | 0.17 | 0.17 | 0.16 | |
Graham Net | -69.5K | -65.55K | -79.4K | -71.97K | -49.61K | |
Working capital | 269.29B | 332.32B | 391.87B | 503.05B | 947.04B | |
Tangible asset value | 1689.82B | 2049.05B | 2449.77B | 2785.75B | 3329.11B | |
Net current asset value | -182.01B | 9.35B | -93.51B | 30.55B | 415.48B | |
Invested capital | 0.2 | 0.14 | 0.17 | 0.1 | 0.1 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 241.34B | 233.38B | 270.93B | 251.19B | 260.88B | |
Average inventory | 677.94B | 711.86B | 777.64B | 808.97B | 904.81B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 34.34 | 29.18 | 36.37 | 30.94 | 32.49 | |
Days of inventory on hand | 81.12 | 83.22 | 93.38 | 99.66 | 120.15 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 10.63 | 12.51 | 10.04 | 11.8 | 11.24 | |
Inventory turnover | 4.5 | 4.39 | 3.91 | 3.66 | 3.04 | |
ROE | 0.2 | 0.19 | 0.19 | 0.17 | 0.16 | |
Capex per share | -19.84K | -24.84K | -22.86K | -35.39K | -22.66K |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 119.96K | 120.72K | 98.16K | 111.15K | 111.61K | |
Net income per share | 14.01K | 7.94K | 6.54K | 7.12K | 7.19K | |
Operating cash flow per share | 5.38K | 29.94K | -7.47K | 10.25K | 7.98K | |
Free cash flow per share | 361.34 | 25.19K | -10.75K | 8.26K | 5.64K | |
Cash per share | 26.8K | 49.52K | 0 | 0 | 0 | |
Book value per share | 311.16K | 321.52K | 315.77K | 314.35K | 326.42K | |
Tangible book value per share | 187.81K | 198.66K | 322.57K | 321.56K | 334K | |
Share holders equity per share | 311.16K | 321.52K | 315.77K | 314.35K | 326.42K | |
Interest debt per share | 32.5K | 31.37K | -60.61 | -44.16 | 77.5 | |
Market cap | 10758.59B | 10322.88B | 8496.27B | 5471.46B | 5521.74B | |
Enterprise value | 10949.66B | 10110.12B | 8496.27B | 5471.46B | 5521.74B | |
P/E ratio | 11.46 | 19.4 | 19.39 | 11.46 | 11.46 | |
Price to sales ratio | 5.35 | 5.1 | 5.16 | 2.94 | 2.95 | |
POCF ratio | 119.25 | 20.57 | -67.89 | 31.86 | 41.27 | |
PFCF ratio | 1.78K | 24.45 | -47.14 | 39.54 | 58.41 | |
P/B Ratio | 2.06 | 1.92 | 1.61 | 1.04 | 1.01 | |
PTB ratio | 2.06 | 1.92 | 1.61 | 1.04 | 1.01 | |
EV to sales | 5.45 | 5 | 5.16 | 2.94 | 2.95 | |
Enterprise value over EBITDA | 27.65 | 37.07 | 37.68 | 29.08 | 32.68 | |
EV to operating cash flow | 121.37 | 20.15 | -67.89 | 31.86 | 41.27 | |
EV to free cash flow | 1.81K | 23.95 | -47.14 | 39.54 | 58.41 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
Free cash flow yield | 0 | 0.04 | -0.02 | 0.03 | 0.02 | |
Debt to equity | 0.03 | 0.03 | 0 | 0 | 0 | |
Debt to assets | 0.28 | 0.27 | 0.27 | 0.28 | 0.28 | |
Net debt to EBITDA | 0.48 | -0.78 | 0 | 0 | 0 | |
Current ratio | 1.58 | 1.62 | 1.63 | 1.65 | 1.78 | |
Interest coverage | 124.68 | 62.21 | -172.87 | -292.66 | 146.34 | |
Income quality | 0.38 | 3.77 | -1.14 | 1.44 | 1.11 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.01 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.45 | 0.45 | 0.46 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.3 | 0.29 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.93 | -0.16 | 0.44 | -0.19 | -0.29 | |
Capex to revenue | -0.04 | -0.04 | -0.03 | -0.02 | -0.02 | |
Capex to depreciation | -1.23 | -1.08 | -0.78 | -0.47 | -0.54 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 313.14K | 239.66K | 215.53K | 224.45K | 229.81K | |
ROIC | 0.06 | 0.04 | 0.03 | 0.04 | 0.03 | |
Return on tangible assets | 0.05 | 0.02 | 0.01 | 0.02 | 0.02 | |
Graham Net | -64.54K | -43.39K | -121.49K | -126.84K | -128.48K | |
Working capital | 864.46B | 947.04B | 922.47B | 931.67B | 1092.71B | |
Tangible asset value | 3147.36B | 3329.11B | 0 | 0 | 0 | |
Net current asset value | 305.39B | 415.48B | 355.71B | 232.64B | 341.17B | |
Invested capital | 0.1 | 0.1 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 32.35 | 29.95 | 0 | 0 | 0 | |
Days of inventory on hand | 121.45 | 110.78 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 2.78 | 3 | 0 | 0 | 0 | |
Inventory turnover | 0.74 | 0.81 | 0 | 0 | 0 | |
ROE | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 | |
Capex per share | -5.02K | -4.75K | -3.29K | -1.99K | -2.34K |
051905.KS Frequently Asked Questions
What is LG Household & Health Care Ltd. stock symbol ?
LG Household & Health Care Ltd. is a KR stock and trading under the symbol 051905.KS
What is LG Household & Health Care Ltd. stock quote today ?
LG Household & Health Care Ltd. stock price is $297500 today.
Is LG Household & Health Care Ltd. stock public?
Yes, LG Household & Health Care Ltd. is a publicly traded company.